Vandetanib for Medullary Thyroid Cancer


( Last Updated : July 13, 2022)
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HD0009-000

Details


This Drug Shortage Implementation Advice synthesizes the evidence on the efficacy and safety of therapeutic alternatives for medullary thyroid cancer and suggests preferred treatment options for use in the event of a supply shortage of vandetanib 100 mg.